Previous close | 2.5400 |
Open | 2.5900 |
Bid | 2.5700 x 200 |
Ask | 3.3200 x 200 |
Day's range | 2.5300 - 2.9000 |
52-week range | 2.1600 - 4.6500 |
Volume | |
Avg. volume | 81,139 |
Market cap | 348.237M |
Beta (5Y monthly) | 1.00 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Explore key financial outcomes and strategic insights from Nautilus Biotechnology's first quarter of 2024, emphasizing growth in expenses and future expectations.
Details on Financial Performance and Strategic Progress Amidst Development Phase
Looking at Nautilus Biotechnology, Inc.'s ( NASDAQ:NAUT ) insider transactions over the last year, we can see that...